GMED
Globus Medical
NYSE: GMED · HEALTHCARE · MEDICAL DEVICES
$90.18
+2.72% today
Updated 2026-04-30
Market cap
$11.91B
P/E ratio
22.40
P/S ratio
4.05x
EPS (TTM)
$3.92
Dividend yield
—
52W range
$52 – $101
Volume
1.1M
Globus Medical (GMED) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+17.7%
Last 4 quarters
Revenue YoY growth
+25.7%
Most recent quarter
EPS YoY growth
+52.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.6%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+11.0%
2025-08-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $1.28 | +11.0% | $91.88 | $96.71 | +5.3% |
| 2025-11-04 | $1.18 | +53.2% | $61.20 | $61.51 | +0.5% |
| 2025-08-07 | $0.86 | +14.7% | $52.83 | $58.65 | +11.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $1.15 | $1.28 | +11.0% | $826.39M | +25.7% |
| 2025-09-30 | $0.77 | $1.18 | +53.2% | $769.05M | +22.9% |
| 2025-06-30 | $0.75 | $0.86 | +14.7% | $745.34M | +18.4% |
| 2025-03-31 | $0.74 | $0.68 | -8.1% | $598.12M | -1.4% |
| 2024-12-31 | $0.75 | $0.84 | +12.2% | $657.29M | +6.6% |
| 2024-09-30 | $0.65 | $0.83 | +27.7% | $625.71M | +63.1% |
| 2024-06-30 | $0.68 | $0.75 | +10.3% | $629.69M | +115.9% |
| 2024-03-31 | $0.57 | $0.72 | +26.3% | $606.67M | +119.3% |
| 2023-12-31 | $0.61 | $0.60 | -1.6% | $616.53M | — |
| 2023-09-30 | $0.57 | $0.57 | +0.0% | $383.64M | — |
| 2023-06-30 | $0.59 | $0.63 | +6.8% | $291.62M | — |
| 2023-03-31 | $0.51 | $0.53 | +3.9% | $276.69M | — |
Frequently asked questions
Has Globus Medical beaten earnings estimates?
Globus Medical has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +17.7% over the last 4 quarters.
How does GMED stock react to earnings?
GMED stock has moved an average of +5.6% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Globus Medical's revenue growth rate?
Globus Medical reported year-over-year revenue growth of +25.7% in its most recent quarter, with EPS growing +52.4% year-over-year.